Detalhe da pesquisa
1.
A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome.
Hum Genet
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642129
2.
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 380(8): 741-751, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30786188
3.
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
Nature
; 527(7579): 472-6, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560033
4.
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
Breast Cancer Res Treat
; 183(1): 227-237, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613539
5.
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Breast Cancer Res
; 21(1): 52, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999962
6.
Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis.
Breast Cancer Res Treat
; 176(3): 535-543, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089928
7.
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
BMC Cancer
; 19(1): 578, 2019 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195996
8.
Personalized Nutrition in Disrupting Cancer - Proceedings From the 2017 American College of Nutrition Annual Meeting.
J Am Coll Nutr
; 38(1): 1-14, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511901
9.
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Lancet Oncol
; 19(6): 812-824, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706375
10.
Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties.
Adv Funct Mater
; 28(44)2018 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30505260
11.
Response to Kochan et al., 2023.
Support Care Cancer
; 31(8): 486, 2023 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480366
12.
Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
Cancer
; 123(19): 3843-3854, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28558150
13.
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.
Oncologist
; 22(3): 245-254, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220020
14.
Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.
Support Care Cancer
; 25(3): 701-708, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27830395
15.
Smart Nanotransformers with Unique Enzyme-Inducible Structural Changes and Drug Release Properties.
Biomacromolecules
; 17(6): 2040-9, 2016 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27180972
16.
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
BMC Cancer
; 15: 267, 2015 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25885598
17.
Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.
Oncologist
; 19(4): 318-27, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24682463
18.
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.
Breast Cancer Res Treat
; 148(3): 553-61, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381136
19.
Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.
Breast Cancer Res Treat
; 146(2): 321-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24699910
20.
Integrative Co-Registration of Elemental Imaging and Histopathology for Enhanced Spatial Multimodal Analysis of Tissue Sections through TRACE.
bioRxiv
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38559138